BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36420859)

  • 21. BAG3-positive pancreatic stellate cells promote migration and invasion of pancreatic ductal adenocarcinoma.
    Yuan Y; Jiang JY; Wang JM; Sun J; Li C; Liu BQ; Yan J; Meng XN; Wang HQ
    J Cell Mol Med; 2019 Aug; 23(8):5006-5016. PubMed ID: 31119886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioengineered tumoral microtissues recapitulate desmoplastic reaction of pancreatic cancer.
    Brancato V; Comunanza V; Imparato G; Corà D; Urciuolo F; Noghero A; Bussolino F; Netti PA
    Acta Biomater; 2017 Feb; 49():152-166. PubMed ID: 27916739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a novel co-culture system using human pancreatic cancer cells and human iPSC-derived stellate cells to mimic the characteristics of pancreatic ductal adenocarcinoma in vitro.
    Kometani T; Kamo K; Kido T; Hiraoka N; Chibazakura T; Unno K; Sekine K
    Biochem Biophys Res Commun; 2023 May; 658():1-9. PubMed ID: 37004297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human pancreatic stellate cells modulate 3D collagen alignment to promote the migration of pancreatic ductal adenocarcinoma cells.
    Drifka CR; Loeffler AG; Esquibel CR; Weber SM; Eliceiri KW; Kao WJ
    Biomed Microdevices; 2016 Dec; 18(6):105. PubMed ID: 27819128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sono-promoted drug penetration and extracellular matrix modulation potentiate sonodynamic therapy of pancreatic ductal adenocarcinoma.
    Xiao H; Li X; Li B; Zhong Y; Qin J; Wang Y; Han S; Ren J; Shuai X
    Acta Biomater; 2023 Apr; 161():265-274. PubMed ID: 36893956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The tumor stroma influences immune cell distribution and recruitment in a PDAC-on-a-chip model.
    Geyer M; Gaul LM; D Agosto SL; Corbo V; Queiroz K
    Front Immunol; 2023; 14():1155085. PubMed ID: 37205118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic mast cell-stromal cell interactions promote growth of pancreatic cancer.
    Ma Y; Hwang RF; Logsdon CD; Ullrich SE
    Cancer Res; 2013 Jul; 73(13):3927-37. PubMed ID: 23633481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer.
    Nagathihalli NS; Castellanos JA; Shi C; Beesetty Y; Reyzer ML; Caprioli R; Chen X; Walsh AJ; Skala MC; Moses HL; Merchant NB
    Gastroenterology; 2015 Dec; 149(7):1932-1943.e9. PubMed ID: 26255562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Epithelial-stromal interactions in pancreatic adenocarcinoma: the role of stroma in disease progression].
    Kuznetsova AV; Popova OP; Astakhov DA; Ivanov YV; Panchenkov DN; Ivanov AA
    Arkh Patol; 2022; 84(5):65-70. PubMed ID: 36178225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic Tumor Microenvironment.
    Wang K; He H
    Adv Exp Med Biol; 2020; 1296():243-257. PubMed ID: 34185297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3.
    Hesler RA; Huang JJ; Starr MD; Treboschi VM; Bernanke AG; Nixon AB; McCall SJ; White RR; Blobe GC
    Carcinogenesis; 2016 Nov; 37(11):1041-1051. PubMed ID: 27604902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic satellite cells derived galectin-1 increase the progression and less survival of pancreatic ductal adenocarcinoma.
    Tang D; Zhang J; Yuan Z; Gao J; Wang S; Ye N; Li P; Gao S; Miao Y; Wang D; Jiang K
    PLoS One; 2014; 9(3):e90476. PubMed ID: 24595374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma.
    Zhao X; Fan W; Xu Z; Chen H; He Y; Yang G; Yang G; Hu H; Tang S; Wang P; Zhang Z; Xu P; Yu M
    Oncotarget; 2016 Dec; 7(49):81110-81122. PubMed ID: 27835602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring.
    Shi Y; Gao W; Lytle NK; Huang P; Yuan X; Dann AM; Ridinger-Saison M; DelGiorno KE; Antal CE; Liang G; Atkins AR; Erikson G; Sun H; Meisenhelder J; Terenziani E; Woo G; Fang L; Santisakultarm TP; Manor U; Xu R; Becerra CR; Borazanci E; Von Hoff DD; Grandgenett PM; Hollingsworth MA; Leblanc M; Umetsu SE; Collisson EA; Scadeng M; Lowy AM; Donahue TR; Reya T; Downes M; Evans RM; Wahl GM; Pawson T; Tian R; Hunter T
    Nature; 2019 May; 569(7754):131-135. PubMed ID: 30996350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silencing PCBP2 normalizes desmoplastic stroma and improves the antitumor activity of chemotherapy in pancreatic cancer.
    Li Y; Zhao Z; Lin CY; Liu Y; Staveley-OCarroll KF; Li G; Cheng K
    Theranostics; 2021; 11(5):2182-2200. PubMed ID: 33500719
    [No Abstract]   [Full Text] [Related]  

  • 36. Photoimmunotherapy Retains Its Anti-Tumor Efficacy with Increasing Stromal Content in Heterotypic Pancreatic Cancer Spheroids.
    Saad MA; Zhung W; Stanley ME; Formica S; Grimaldo-Garcia S; Obaid G; Hasan T
    Mol Pharm; 2022 Jul; 19(7):2549-2563. PubMed ID: 35583476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression.
    Chen K; Wang Q; Li M; Guo H; Liu W; Wang F; Tian X; Yang Y
    EBioMedicine; 2021 Apr; 66():103315. PubMed ID: 33819739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts.
    Liu H; Shi Y; Qian F
    Adv Drug Deliv Rev; 2021 May; 172():37-51. PubMed ID: 33705881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Desmoplasia suppression by metformin-mediated AMPK activation inhibits pancreatic cancer progression.
    Duan W; Chen K; Jiang Z; Chen X; Sun L; Li J; Lei J; Xu Q; Ma J; Li X; Han L; Wang Z; Wu Z; Wang F; Wu E; Ma Q; Ma Z
    Cancer Lett; 2017 Jan; 385():225-233. PubMed ID: 27773749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Biomimetic Tumor Model of Heterogeneous Invasion in Pancreatic Ductal Adenocarcinoma.
    Bradney MJ; Venis SM; Yang Y; Konieczny SF; Han B
    Small; 2020 Mar; 16(10):e1905500. PubMed ID: 31997571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.